Copernicus Capital Management »

Proqr Thrapeutics N V shs euro shares owned by Copernicus Capital Management

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Copernicus Capital Management from 13F filings

Historical chart of Copernicus Capital Management investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Copernicus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Copernicus Capital Management

Quarter filed Position value Share count Share price at filing
2021-09-30 $335k 40k 8.38

More positions owned by Copernicus Capital Management

Pfizer (PFE)
Thermo Fisher Scientific (TMO)
Teladoc (TDOC)
BioMarin Pharmaceutical (BMRN)
Johnson & Johnson (JNJ)
Fate Therapeutics (FATE)
Horizon Therapeutics Pub L SHS
Arcus Biosciences Incorporated (RCUS)
Allogene Therapeutics (ALLO)
Medtronic SHS (MDT)
Proqr Thrapeutics N V Shs Euro (PRQR)
Immatics SHS (IMTX)
Amicus Therapeutics (FOLD)

View all positions for Copernicus Capital Management

Top funds holding Proqr Thrapeutics N V shs euro

Privium Fund Management B.V.
EcoR1 Capital
M28 Capital Management
DAFNA Capital Management
Ghost Tree Capital
Macquarie Group
Ikarian Capital
Schonfeld Strategic Advisors
Monaco Asset Management SAM
Franklin Street Advisors
Two Sigma Advisers
Deutsche Bank Aktiengesellschaft
Susquehanna International
Acadian Asset Management
Citadel Advisors

View all funds holding Proqr Thrapeutics N V shs euro